Lei Yang

4PUBLICATIONS
76CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

|Sep 28, 2023
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression.

Wen-Hao Hsu, Kyle A LaBella, Yiyun Lin

|Sep 13, 2023
Peroxisome proliferator-activated receptors as therapeutic target for cancer.

Yuqing Wang, Feifei Lei, Yiyun Lin

|Jul 08, 2022
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

Jacob D Soumerai, Allison Rosenthal, Shannon Harkins

Pageof 1